---
title: 13F filings, Q1 2014
canonical: https://sweetvaluelab.com/investors/13f/2014-q1
quarter: 2014-03-31
deadline: 2014-05-15
filed: 2014-07-14
---
# 13F filings, Q1 2014

Holdings as of Mar 31, 2014, due by May 15, 2014. 65 of 85 tracked investors have filed; changes are computed for the 65 with holdings in both Q1 2014 and the quarter before. Stock positions only.

## New buys

| Security | Investors | Value |
| --- | ---: | ---: |
| VOD (first appearance: spin-off or new listing) | 8 | $460.4M |
| VZ | 6 | $790.6M |
| LIBERTY GLOBAL PLC | 4 | $734.1M |
| ENDO INTL PLC (first appearance: spin-off or new listing) | 4 | $335.4M |
| ASHLAND INC NEW | 4 | $314.6M |
| KN (first appearance: spin-off or new listing) | 4 | $159.0M |
| NOVEUR | 3 | $1.1B |
| ACTAVIS PLC | 3 | $1.1B |
| CTRPUSD | 3 | $220.3M |
| CTXSEUR | 3 | $157.1M |

## Sold out

| Security | Investors | Value sold |
| --- | ---: | ---: |
| VODAFONE GROUP PLC NEW | 7 | $1.1B |
| GOOGLE | 5 | $1.1B |
| Endo Health Sol'ns Inc. | 5 | $359.8M |
| AMZN | 4 | $411.3M |
| MET | 4 | $109.9M |
| TIME WARNER CABLE INC | 4 | $106.0M |
| HEWLETT PACKARD CO | 4 | $13.7M |
| YAHOO INC | 3 | $790.1M |
| AXP | 3 | $553.0M |
| C | 3 | $428.8M |

## Net bought

| Security | Buyers / sellers | Net |
| --- | ---: | ---: |
| LIBERTY GLOBAL PLC | 14 / 0 | +$2.8B |
| AAPL | 12 / 7 | +$1.8B |
| EBAY | 8 / 5 | +$1.5B |
| NOVEUR | 12 / 1 | +$1.4B |
| VZ | 12 / 2 | +$1.0B |
| ILMN | 2 / 1 | +$1.0B |
| Walgreen Co | 4 / 4 | +$919.8M |
| BIDU | 5 / 4 | +$823.8M |
| LVS | 1 / 1 | +$820.6M |
| WMT | 9 / 6 | +$808.8M |

## Net sold

| Security | Buyers / sellers | Net |
| --- | ---: | ---: |
| DIRECTV | 3 / 5 | −$1.6B |
| CVS | 5 / 5 | −$1.6B |
| Google Inc. | 6 / 14 | −$1.5B |
| AXP | 2 / 12 | −$1.4B |
| PSX | 1 / 4 | −$1.3B |
| VODAFONE GROUP PLC NEW | 0 / 8 | −$1.1B |
| FOREST LABS INC | 0 / 4 | −$1.1B |
| DELPHI AUTOMOTIVE PLC | 0 / 5 | −$950.0M |
| GM | 6 / 5 | −$905.4M |
| PRICELINE COM INC | 5 / 6 | −$811.8M |

## Selected investors

| Investor | Largest moves |
| --- | --- |
| Buffett (Berkshire Hathaway Inc) | reduced PSX −$1.3B; added WMT +$654.9M; bought VZ +$524.4M; reduced GM −$344.2M; bought LIBERTY GLOBAL PLC +$299.1M |
| Druckenmiller (Duquesne Family Office LLC) | sold SLB −$89.5M; sold DAL −$85.4M; bought Walgreen Co +$81.9M; bought MSFT +$70.7M; sold AMZN −$62.9M |
| Soros (Soros Fund Management LLC) | reduced PXDEUR −$166.6M; sold JPM −$166.2M; reduced DRIV 2 11/01/30 −$150.0M; added LIBERTY GLOBAL PLC +$127.0M; sold JCPCHF −$126.6M |
| Bridgewater (Bridgewater Associates, LP) | added MSFT +$19.9M; added SYMCEUR +$19.0M; sold AXP −$18.2M; added INTC +$17.5M; reduced PEP −$17.3M |
| Ackman (Pershing Square Inc.) | reduced BEAM INC −$762.2M; bought PLATFORM SPECIALTY PRODS COR +$635.0M; sold GENERAL GROWTH PPTYS INC NEW −$554.4M; bought APARTMENT INVT & MGMT CO +$113.3M; bought ALLERGAN INC +$74.1M |
| Klarman (Baupost Group LLC) | bought LNG +$313.3M; reduced BP −$120.2M; bought KERYX BIOPHARMACEUTICALS INC +$107.5M; added IDENIX PHARMACEUTICALS INC +$93.2M; added PBF +$88.8M |
| Tepper (Appaloosa LP) | added HAL +$237.4M; added GOOGLE INC +$229.1M; bought PRICELINE COM INC +$218.4M; added GM +$100.4M; sold FLR −$97.7M |
| Loeb (Third Point LLC) | bought ACTAVIS PLC +$514.6M; sold YAHOO INC −$323.5M; bought CF +$251.9M; added LIBERTY GLOBAL PLC +$183.2M; bought VZ +$166.5M |

Not filed for Q1 2014: Burry (last: none), Li Lu (last: none), Duan Yongping (last: none), Norbert Lou (last: none), Henry Ellenbogen (last: none), Valley Forge (last: none), Clifford Sosin (last: none), AltaRock (last: none), Francois Rochon (last: none), Bryan Lawrence (last: none), Pat Dorsey (last: none), Chris Hohn (last: none), AKO Capital (last: none), Hillman Capital (last: 2013-12-31), Greg Alexander (last: none), Dennis Hong (last: none), Samantha McLemore (last: none), Robert Vinall (last: none), Josh Tarasoff (last: none), Guy Spier (last: none).

---

Source: https://sweetvaluelab.com/investors/13f/2014-q1 (SweetValueLab, free, no account). Holdings from SEC Form 13F-HR filings; tickers resolved from CUSIPs; share changes priced at each quarter's reported value. Research and educational data, not investment advice; nothing here is a recommendation to buy, sell or hold any security.